Gao, J., Cheng, J., Fiero, M., Tang, S., Wedam, S. B., Royce, M. E., Prowell, T. M., Chang, E., Shah, M., Narayan, P., Osgood, C., Gormley, N., Kim, T., Pazdur, R., Kluetz, P. G., Amiri-Kordestani, L. (2025). Overall survival in patients with HR+/HER2- advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus an aromatase inhibitor: A US Food and Drug Administration pooled analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1055